Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell
• Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
Cramer Weighs In On Lennar, Alibaba And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he needs something less speculative than Original BARK Co (NYSE: BARK).
This Robot-Run ETF Of Tesla Fame Sold Snapchat, AMD In August And Loaded Up On These Big Tech Stocks Instead
The Qraft AI-Enhanced US Large Cap Momentum ETF (NYSE: AMOM), an exchange-traded fund driven by artificial intelligence, bought into Amazon.com Inc. (NASDAQ: AMZN), Facebook Inc. (NASDAQ:
10 Biggest Price Target Changes For Friday
Telsey Advisory Group raised Target Corporation (NYSE: TGT) price target from $265 to $305. Target shares rose 0.1% to $262.00 in pre-market trading.
Credit Suisse Maintains Outperform on IDEXX Laboratories, Raises Price Target to $770
Credit Suisse analyst Katie Tryhane maintains IDEXX Laboratories (NASDAQ:IDXX) with a Outperform and raises the price target from $735 to $770.
Tesla Fame’s Robot-Run ETF Added Snapchat, Zoom And This WallStreetBets-Favorite Stock In July
The Qraft AI-Enhanced US Large Cap Momentum ETF (NYSE: AMOM), an exchange-traded fund driven by artificial intelligence, has acquired stakes in Reddit-favorite stock Advanced Micro Devices Inc.
Goldman Sachs Maintains Neutral on IDEXX Laboratories, Raises Price Target to $610
Goldman Sachs maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $550 to $610.
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $750
Barclays analyst Balaji Prasad maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $616 to $750.
IDEXX Laboratories Q2 EPS $2.34 Beats $2.04 Estimate, Sales $826.00M Beat $782.99M Estimate; Raises Guidance
IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $2.34 per share which beat the analyst consensus estimate of $2.04 by 14.71 percent. This is a 36.05 percent increase over earnings of $1.72 per share from
Earnings Scheduled For July 30, 2021
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter.